Global Non-Invasive Drug Delivery Market Research Report 2021

1 Non-Invasive Drug Delivery Market Overview

• 1.1 Product Overview and Scope of Non-Invasive Drug Delivery
• 1.2 Non-Invasive Drug Delivery Segment by Type
  • 1.2.1 Global Non-Invasive Drug Delivery Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Artificial Pancreas
  • 1.2.3 Needle Free Injector
  • 1.2.4 Digital Respiratory Devices
  • 1.2.5 Other
• 1.3 Non-Invasive Drug Delivery Segment by Application
  • 1.3.1 Non-Invasive Drug Delivery Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Non-Invasive Drug Delivery Market Size Estimates and Forecasts
  • 1.4.1 Global Non-Invasive Drug Delivery Revenue 2016-2027
  • 1.4.2 Global Non-Invasive Drug Delivery Sales 2016-2027
  • 1.4.3 Non-Invasive Drug Delivery Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-Invasive Drug Delivery Market Competition by Manufacturers

• 2.1 Global Non-Invasive Drug Delivery Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Non-Invasive Drug Delivery Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Non-Invasive Drug Delivery Manufacturing Sites, Area Served, Product Type
• 2.5 Non-Invasive Drug Delivery Market Competitive Situation and Trends
  • 2.5.1 Non-Invasive Drug Delivery Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Non-Invasive Drug Delivery Players Market Share by Revenue
  • 2.5.3 Global Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-Invasive Drug Delivery Retrospective Market Scenario by Region

• 3.1 Global Non-Invasive Drug Delivery Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Non-Invasive Drug Delivery Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Non-Invasive Drug Delivery Market Facts & Figures by Country
  • 3.3.1 North America Non-Invasive Drug Delivery Sales by Country
  • 3.3.2 North America Non-Invasive Drug Delivery Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Non-Invasive Drug Delivery Market Facts & Figures by Country
  • 3.4.1 Europe Non-Invasive Drug Delivery Sales by Country
  • 3.4.2 Europe Non-Invasive Drug Delivery Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Non-Invasive Drug Delivery Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Non-Invasive Drug Delivery Sales by Region
  • 3.5.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Non-Invasive Drug Delivery Market Facts & Figures by Country
  • 3.6.1 Latin America Non-Invasive Drug Delivery Sales by Country
  • 3.6.2 Latin America Non-Invasive Drug Delivery Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Non-Invasive Drug Delivery Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Country
  • 3.7.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Non-Invasive Drug Delivery Historic Market Analysis by Type

• 4.1 Global Non-Invasive Drug Delivery Sales Market Share by Type (2016-2021)
• 4.2 Global Non-Invasive Drug Delivery Revenue Market Share by Type (2016-2021)
• 4.3 Global Non-Invasive Drug Delivery Price by Type (2016-2021)

5 Global Non-Invasive Drug Delivery Historic Market Analysis by Application

• 5.1 Global Non-Invasive Drug Delivery Sales Market Share by Application (2016-2021)
• 5.2 Global Non-Invasive Drug Delivery Revenue Market Share by Application (2016-2021)
• 5.3 Global Non-Invasive Drug Delivery Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Adherium Limited
  • 6.1.1 Adherium Limited Corporation Information
  • 6.1.2 Adherium Limited Description and Business Overview
  • 6.1.3 Adherium Limited Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Adherium Limited Product Portfolio
  • 6.1.5 Adherium Limited Recent Developments/Updates
• 6.2 Capsule Technologies, Inc.
  • 6.2.1 Capsule Technologies, Inc. Corporation Information
  • 6.2.2 Capsule Technologies, Inc. Description and Business Overview
  • 6.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Capsule Technologies, Inc. Product Portfolio
  • 6.2.5 Capsule Technologies, Inc. Recent Developments/Updates
• 6.3 Crossject S.A.
  • 6.3.1 Crossject S.A. Corporation Information
  • 6.3.2 Crossject S.A. Description and Business Overview
  • 6.3.3 Crossject S.A. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Crossject S.A. Product Portfolio
  • 6.3.5 Crossject S.A. Recent Developments/Updates
• 6.4 Diabeloop SA
  • 6.4.1 Diabeloop SA Corporation Information
  • 6.4.2 Diabeloop SA Description and Business Overview
  • 6.4.3 Diabeloop SA Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Diabeloop SA Product Portfolio
  • 6.4.5 Diabeloop SA Recent Developments/Updates
• 6.5 HNS International, Inc.
  • 6.5.1 HNS International, Inc. Corporation Information
  • 6.5.2 HNS International, Inc. Description and Business Overview
  • 6.5.3 HNS International, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 HNS International, Inc. Product Portfolio
  • 6.5.5 HNS International, Inc. Recent Developments/Updates
• 6.6 Inovio Pharmaceuticals, Inc.
  • 6.6.1 Inovio Pharmaceuticals, Inc. Corporation Information
  • 6.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
  • 6.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Inovio Pharmaceuticals, Inc. Product Portfolio
  • 6.6.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates
• 6.7 Medtronic Plc.
  • 6.6.1 Medtronic Plc. Corporation Information
  • 6.6.2 Medtronic Plc. Description and Business Overview
  • 6.6.3 Medtronic Plc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Medtronic Plc. Product Portfolio
  • 6.7.5 Medtronic Plc. Recent Developments/Updates
• 6.8 Novartis AG
  • 6.8.1 Novartis AG Corporation Information
  • 6.8.2 Novartis AG Description and Business Overview
  • 6.8.3 Novartis AG Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Novartis AG Product Portfolio
  • 6.8.5 Novartis AG Recent Developments/Updates
• 6.9 PenJet Corporation
  • 6.9.1 PenJet Corporation Corporation Information
  • 6.9.2 PenJet Corporation Description and Business Overview
  • 6.9.3 PenJet Corporation Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 PenJet Corporation Product Portfolio
  • 6.9.5 PenJet Corporation Recent Developments/Updates
• 6.10 PharmaJet
  • 6.10.1 PharmaJet Corporation Information
  • 6.10.2 PharmaJet Description and Business Overview
  • 6.10.3 PharmaJet Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 PharmaJet Product Portfolio
  • 6.10.5 PharmaJet Recent Developments/Updates
• 6.11 Portal Instruments
  • 6.11.1 Portal Instruments Corporation Information
  • 6.11.2 Portal Instruments Non-Invasive Drug Delivery Description and Business Overview
  • 6.11.3 Portal Instruments Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Portal Instruments Product Portfolio
  • 6.11.5 Portal Instruments Recent Developments/Updates
• 6.12 ResMed
  • 6.12.1 ResMed Corporation Information
  • 6.12.2 ResMed Non-Invasive Drug Delivery Description and Business Overview
  • 6.12.3 ResMed Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 ResMed Product Portfolio
  • 6.12.5 ResMed Recent Developments/Updates
• 6.13 Sensiron AG
  • 6.13.1 Sensiron AG Corporation Information
  • 6.13.2 Sensiron AG Non-Invasive Drug Delivery Description and Business Overview
  • 6.13.3 Sensiron AG Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Sensiron AG Product Portfolio
  • 6.13.5 Sensiron AG Recent Developments/Updates
• 6.14 Tandem Diabetes Care, Inc.
  • 6.14.1 Tandem Diabetes Care, Inc. Corporation Information
  • 6.14.2 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Description and Business Overview
  • 6.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Tandem Diabetes Care, Inc. Product Portfolio
  • 6.14.5 Tandem Diabetes Care, Inc. Recent Developments/Updates
• 6.15 Teva Pharmaceuticals Industries Ltd.
  • 6.15.1 Teva Pharmaceuticals Industries Ltd. Corporation Information
  • 6.15.2 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Description and Business Overview
  • 6.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Teva Pharmaceuticals Industries Ltd. Product Portfolio
  • 6.15.5 Teva Pharmaceuticals Industries Ltd. Recent Developments/Updates

7 Non-Invasive Drug Delivery Manufacturing Cost Analysis

• 7.1 Non-Invasive Drug Delivery Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Non-Invasive Drug Delivery
• 7.4 Non-Invasive Drug Delivery Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Non-Invasive Drug Delivery Distributors List
• 8.3 Non-Invasive Drug Delivery Customers

9 Non-Invasive Drug Delivery Market Dynamics

• 9.1 Non-Invasive Drug Delivery Industry Trends
• 9.2 Non-Invasive Drug Delivery Growth Drivers
• 9.3 Non-Invasive Drug Delivery Market Challenges
• 9.4 Non-Invasive Drug Delivery Market Restraints

10 Global Market Forecast

• 10.1 Non-Invasive Drug Delivery Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Non-Invasive Drug Delivery by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Non-Invasive Drug Delivery by Type (2022-2027)
• 10.2 Non-Invasive Drug Delivery Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Non-Invasive Drug Delivery by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Non-Invasive Drug Delivery by Application (2022-2027)
• 10.3 Non-Invasive Drug Delivery Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Non-Invasive Drug Delivery by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Non-Invasive Drug Delivery by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List